6-K 1 tm1926623d1_6k.htm FORM 6-K

 

 

 

FORM 6-K
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

 

Report of Foreign Private Issuer

 

Pursuant to Rule 13a-16 or 15d-16 of
the Securities Exchange Act of 1934

 

For the month of December, 2019

 

Commission File Number: 001-38562

 

NEW FRONTIER HEALTH CORPORATION
(Translation of Registrant’s Name into English)

 

23rd Floor, 299 QRC

287-299 Queen’s Road Central

Hong Kong
(Address of principal executive office)

 

Indicate by check mark whether the registrant files or will file
annual reports under cover of Form 20-F or Form 40-F:

 

Form 20-F x Form 40-F ¨

 

Indicate by check mark if the registrant is submitting the Form 6-K
in paper as permitted by Regulation S-T Rule 101(b)(1):

 

Yes ¨ No x

 

Indicate by check mark if the registrant is submitting the Form 6-K
in paper as permitted by Regulation S-T Rule 101(b)(7):

 

Yes ¨ No x

 

 

 

 

 

 

INFORMATION CONTAINED IN THIS FORM 6-K REPORT

 

On December 19, 2019, New Frontier Health Corporation (f/k/a New Frontier Corporation) (the “Company”) issued a press release announcing that the Company has consummated its business combination with United Family Healthcare.

 

A copy of the press release is attached as Exhibit 99.1 hereto.

 

Exhibit 99.1 to this Report on Form 6-K shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, (the “Exchange Act”) or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act.

 

EXHIBIT INDEX

 

Exhibit Description of Exhibit
99.1 Press Release dated December 19, 2019.

 

 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

  New Frontier Health Corporation
     
  By: /s/ Roberta Lipson
    Name: Roberta Lipson
    Title: Chief Executive Officer

 

Date: December 20, 2019